# V1 Empirics Check — openai/gpt-5.4 (Variant C)

**Model:** openai/gpt-5.4
**Variant:** C
**Date:** 2026-03-31T10:08:21.620823

---

## 1. **Idea Fidelity**

The paper pursues the broad manifest idea, but only partially and in some important ways not faithfully.

First, the paper does study Korea’s mandatory English disclosure rule and focuses on liquidity, which is the core research question in the manifest. It also uses a DiD/event-study framework around the 2024 Phase 1 rollout. So the central theme is preserved.

However, several key elements of the original design are missing or weakened:

- **Treatment definition is not faithful to the policy.** The paper classifies treatment using only the **KRW 10 trillion asset threshold**, but the manifest and the institutional description state that Phase 1 also required **foreign ownership ≥ 5%**. Ignoring this second eligibility condition creates likely treatment misclassification.
- **The paper drops most of the market ex ante** by restricting to the top 300 firms by market cap. The manifest envisioned the broader KOSPI universe; trimming the sample in this way changes the estimand and may mechanically improve comparability while reducing external validity.
- **The paper does not deliver on the “Korea discount” outcomes.** The manifest emphasized foreign ownership and valuation/PB as economically central outcomes. The paper instead focuses almost entirely on Amihud illiquidity and turnover, with no convincing evidence on valuation.
- **The proposed triple-difference to separate the disclosure reform from the November 2023 abolition of foreign investor registration is not implemented.** Instead, the paper asserts that week fixed effects absorb common shocks. That is not enough if large firms were differentially affected by the concurrent reform bundle.
- **The RDD is acknowledged but not informative**, which is fine, but that leaves the paper relying almost entirely on a DiD design with problematic pre-trends.

So: the paper follows the spirit of the idea, but not the stronger identification strategy or the broader economic question laid out in the manifest.

## 2. **Summary**

This paper studies whether Korea’s 2024 mandatory English disclosure requirement improved stock market liquidity for large KOSPI firms. Using a firm-by-week DiD, it finds no statistically significant average effect on illiquidity or turnover, but reports a large and significant decline in illiquidity for financial firms.

The topic is interesting and potentially important. But in its current form, the paper does not yet establish a clean causal effect of English disclosure, nor does it convincingly show an economically meaningful effect on the broader “Korea discount.”

## 3. **Essential Points**

1. **Identification is not credible enough in the current DiD.** The paper’s own event study rejects the null of no pre-trends in the pooled sample. That is a first-order problem, not a footnote. On top of that, treatment is based on a size threshold that is mechanically correlated with international orientation, analyst coverage, and likely exposure to the November 2023 registration reform and the 2024 Value-Up initiative. Week fixed effects absorb common shocks, but not differential effects on the largest firms. As written, the causal interpretation is too strong.

2. **The treatment variable appears mismeasured, and the timing is too coarse.** Phase 1 eligibility depended not just on assets but also on foreign ownership. Moreover, “January 2024” is not obviously the economically relevant treatment date: filings occur intermittently, the English DART portal launched in February 2024, and disclosure effects should arrive when the first translated filing becomes available, not necessarily at the first week of January. This matters a lot for both magnitude and standard errors.

3. **The headline financial-sector effect is intriguing but not yet persuasive.** A 33 percent drop in Amihud illiquidity for financial firms is large relative to the weak pooled results and somewhat hard to reconcile with the mechanism, given that the mandate affects periodic filings, not continuous information flow. The paper needs much more evidence that this is not a sector-specific confound, a composition effect, or a functional-form artifact. Right now the strongest result looks more like an exploratory heterogeneity finding than a settled causal estimate.

## 4. **Suggestions**

The paper is promising, but it needs a much tighter empirical design and a more disciplined interpretation. My suggestions below are mostly aimed at making the core result publishable.

**1. Rebuild the treatment assignment from the actual regulation.**  
This should be the first task. Use the official FSC/FSS list of firms subject to Phase 1, or at minimum reconstruct eligibility using both:
- total assets ≥ KRW 10 trillion, and
- foreign ownership ≥ 5%.

If you cannot observe foreign ownership, say so clearly and either obtain the official treated list or recast the design as an “intent-to-treat based on size threshold,” not as the mandatory treatment itself. At present, the paper overstates precision in treatment coding.

**2. Move from a January-2024 step function to filing-level treatment timing.**  
The current design assumes all treated firms become exposed at once in early January 2024. That is not how disclosure mandates work. Investors learn from the first relevant English filing, and firms likely vary in:
- first filing date,
- completeness of English translation,
- filing type,
- compliance timing.

A much better design would define treatment onset at the **first mandatory English filing** for each firm and estimate an event study around that date. This would sharpen the mechanism considerably and also reduce attenuation from mistimed treatment.

**3. Address the pre-trends problem directly, not rhetorically.**  
The paper currently says the joint pre-trend test rejects because of two outlier months. That is not an adequate response. You should:
- show the full event-study graph with confidence bands,
- report both the full pre-trend test and a test on a narrower pre-window,
- estimate specifications with **firm-specific linear trends**,
- consider matching or reweighting treated and control firms on pre-period liquidity, size, sector, analyst coverage, and foreign ownership exposure if available,
- report a stacked DiD or local comparison around the threshold if feasible.

If pre-trends remain problematic, the paper should scale back causal language.

**4. Use the threshold more seriously.**  
The RDD is underpowered, but the threshold remains useful. Several options:
- restrict the DiD sample to firms in a bandwidth around the KRW 10 trillion cutoff;
- show local balance on observables around the threshold;
- use a “difference-in-discontinuities” logic if you can compare pre/post slope changes near the threshold;
- at minimum, present estimates for increasingly narrow windows around the asset cutoff.

That would be more convincing than comparing the 81 largest firms to a broad set of 214 smaller controls.

**5. Reconsider standard error inference.**  
Firm-level clustering is not obviously wrong, but it is not enough to reassure me here. You have serial correlation, common treatment timing, and a modest number of treated firms. I would like to see:
- **wild cluster bootstrap** p-values at the firm level,
- randomization-inference or permutation-based p-values using placebo treatment assignments among similar-size firms,
- two-way clustering by firm and calendar time if feasible,
- clear discussion of how many treated clusters exist in each heterogeneity split, especially in finance.

Also, the appendix statement that clustering at the sector level gives essentially the same SE is not informative and may even be misleading if the number of sectors is small. With few sector clusters, conventional cluster asymptotics are unreliable.

**6. Be much more cautious about the magnitude of the financial-sector estimate.**  
A 0.397 log-point decline in Amihud is economically large. That does not make it impossible, but it does require validation. I would suggest:
- report the effect in levels as well as logs,
- show baseline Amihud distributions by sector and treatment status,
- winsorize more aggressively or use inverse hyperbolic sine / level specifications to assess sensitivity,
- show whether the result is driven by a few thinly traded financial names,
- report leave-one-out estimates dropping each treated financial firm in turn,
- verify that the result is not concentrated in one event window or one subindustry, e.g. banks only.

At present, the paper’s strongest claim rests on a coefficient that may be quite sensitive to a small number of observations.

**7. Improve the market microstructure measurement.**  
The Amihud ratio is standard, but your implementation needs to be cleaner and more transparent. In the paper, the construction is described inconsistently: one place refers to trading volume in KRW, another to shares scaled by price. You should specify exactly:
- whether returns are close-to-close log returns,
- whether volume is shares or value traded,
- whether prices and volumes are adjusted for splits,
- how you handle zero-volume days, suspended trading, and outliers.

Yahoo Finance is convenient, but for a paper of this type I would much rather see **KRX-based or DART-linked official data** if available. At minimum, validate Yahoo measures against an alternative source for a subset of firms.

**8. The significant increase in absolute returns needs better interpretation.**  
The paper interprets higher absolute returns as “price informativeness.” That is too quick. Higher absolute returns can equally reflect higher volatility unrelated to information efficiency. Since the paper finds weak average effects on liquidity and turnover, but strong effects on absolute returns, the volatility result may be a warning sign rather than supporting evidence. You should:
- test realized volatility separately from liquidity,
- examine whether the effect is concentrated around filing dates,
- show whether price efficiency proxies improve, rather than simply volatility increasing.

I would not present the volatility result as supportive without stronger evidence.

**9. Do not infer too much from “several significant months” in the event study.**  
Pointing to individually significant post-treatment months is not persuasive when many monthly coefficients are estimated. This reads as post hoc selection. Better to:
- plot all coefficients,
- test average post effects over pre-specified windows,
- correct interpretation for multiple testing or avoid month-by-month significance language entirely.

**10. Bring back the economically important outcomes from the manifest.**  
For AER: Insights format, the paper needs one clear result of broader economic significance. Liquidity alone may be enough if the design is clean, but your title and framing promise much more. If possible, add:
- foreign ownership,
- valuation measures such as market-to-book or Tobin’s q,
- bid-ask spread or other direct liquidity proxies,
- analyst coverage or forecast dispersion if available.

If the reform truly reduces a language barrier, foreign participation is the most natural channel test. Without it, the mechanism remains fairly speculative.

**11. Tighten the interpretation of the “Korea discount.”**  
The paper currently overreaches. You do not estimate an effect on the Korea discount; you estimate, at best, a liquidity effect for one subset of firms. I would either:
- tone down the title and introduction to focus on liquidity, or
- add direct evidence on valuation and foreign participation.

As written, the paper’s rhetoric outruns its evidence.

**12. Clarify the sample restriction to the top 300 firms and justify the estimand.**  
This restriction is consequential. Why should readers believe the top-300 comparison is the relevant one? If the answer is data quality or comparability, show that. Otherwise estimate on:
- the full KOSPI sample,
- the top 300,
- a matched sample,
- a local-threshold sample.

That would reveal whether the result is robust or sample-dependent.

**13. Reframe the paper around what it truly shows.**  
Right now the paper presents a null pooled effect and a strong subgroup effect, then treats the subgroup effect as the main conclusion. That can be fine, but only if the subgroup analysis is clearly motivated ex ante and convincingly identified. To strengthen that case:
- show that finance was pre-specified by mechanism,
- report the number of treated financial firms,
- test whether the finance/non-finance difference is itself statistically significant,
- include interactions rather than separate split-sample regressions.

A formal triple interaction is cleaner than juxtaposing two columns.

**14. Improve exposition and internal consistency.**  
There are several small but noticeable issues:
- summary statistics reported in text do not match the table exactly;
- the treatment count differs from the manifest’s ~111 and paper’s 81, likely because of sample restriction, but this should be explained clearly;
- the paper claims DART-based institutional detail but uses FinanceDataReader rather than the DART API for core classification.

These are fixable, but they matter for credibility.

Overall, this is a good topic and a plausible setting, but the current version is not yet a convincing causal paper. My recommendation is not to abandon it, but to **rebuild the design around actual treated firms and actual filing dates**, and to substantially moderate the claims unless and until the identification is tighter. If the financial-sector result survives those changes, then you may indeed have a clear and interesting paper.
